These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21421583)

  • 41. Antiretroviral therapy-associated diseases are common in the long-term.
    Lanzafame M; Lattuada E; Zoppini G; Vento S
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population.
    Nachega JB; Hsu AJ; Uthman OA; Spinewine A; Pham PA
    AIDS; 2012 Jul; 26 Suppl 1():S39-53. PubMed ID: 22781176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [HIV infection in France in 2012: reality, risks and challenges for a chronic multisystem disease].
    Blot M; Piroth L
    Rev Mal Respir; 2012 Jun; 29(6):785-92. PubMed ID: 22742465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals.
    Achhra AC; Petoumenos K; Law MG
    Curr Opin HIV AIDS; 2014 Jan; 9(1):63-71. PubMed ID: 24275674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV and the kidney.
    Post FA; Hendry BM
    Br J Hosp Med (Lond); 2008 Mar; 69(3):137-40. PubMed ID: 18422216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV: a growing concern in the elderly population.
    Vouri SM; Blaszczyk AT
    Consult Pharm; 2012 May; 27(5):358-64. PubMed ID: 22591980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral molecules and cardiovascular diseases.
    Gibellini D; Borderi M; Clò A; Morini S; Miserocchi A; Bon I; Re MC
    New Microbiol; 2012 Oct; 35(4):359-75. PubMed ID: 23109004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Inflammation and HIV].
    Bricaire F; Valantin MA
    Bull Acad Natl Med; 2011 Mar; 195(3):531-42; discussion 543-4. PubMed ID: 22292303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV infection and aging of the innate immune system.
    Hearps AC; Angelovich TA; Jaworowski A; Mills J; Landay AL; Crowe SM
    Sex Health; 2011 Dec; 8(4):453-64. PubMed ID: 22127030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pilot study to assess subjective and objective reporting of potential adverse drug reactions in older versus younger HIV-infected patients using antiretroviral therapy.
    Hirsch AA; Compan A; Lawrence RH; Briggs JM; Yadavalli GK; Fuller MA
    J Assoc Nurses AIDS Care; 2012; 23(5):397-408. PubMed ID: 22137548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging concepts on the use of antiretroviral therapy in older adults living with HIV infection.
    Winston A; Underwood J
    Curr Opin Infect Dis; 2015 Feb; 28(1):17-22. PubMed ID: 25377310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of evidence-based exercise recommendations for older HIV-infected patients.
    Yahiaoui A; McGough EL; Voss JG
    J Assoc Nurses AIDS Care; 2012; 23(3):204-19. PubMed ID: 21803606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complications of Treatment in Youth with HIV.
    Eckard AR; Fowler SL; Haston JC; Dixon TC
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):226-33. PubMed ID: 27234970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aging and living with HIV/AIDS.
    Jang H; Anderson PG; Mentes JC
    J Gerontol Nurs; 2011 Dec; 37(12):4-7. PubMed ID: 22084965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment.
    McCabe SM; Ma Q; Slish JC; Catanzaro LM; Sheth N; DiCenzo R; Morse GD
    Clin Pharmacokinet; 2008; 47(3):153-72. PubMed ID: 18307370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
    Deeks SG; Phillips AN
    BMJ; 2009 Jan; 338():a3172. PubMed ID: 19171560
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronological and biological age in HIV infection.
    De Socio GV; Ricci E; Parruti G; Maggi P; Madeddu G; Quirino T; Bonfanti P
    J Infect; 2010 Nov; 61(5):428-30. PubMed ID: 20833202
    [No Abstract]   [Full Text] [Related]  

  • 58. Managing HIV-associated inflammation and ageing in the era of modern ART.
    Bloch M; John M; Smith D; Rasmussen TA; Wright E
    HIV Med; 2020 Oct; 21 Suppl 3():2-16. PubMed ID: 33022087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
    Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG;
    J Int AIDS Soc; 2012 Oct; 15(2):17426. PubMed ID: 23078769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ageing with HIV: medication use and risk for potential drug-drug interactions.
    Marzolini C; Back D; Weber R; Furrer H; Cavassini M; Calmy A; Vernazza P; Bernasconi E; Khoo S; Battegay M; Elzi L;
    J Antimicrob Chemother; 2011 Sep; 66(9):2107-11. PubMed ID: 21680580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.